Comment in 2022

Filter By:

Article Type
Year
  • Social media has revolutionized health-care communication across medicine, particularly in the field of oncology. In this Comment, Manochakian and Dizon highlight the role of social media in promoting patient-driven cancer research to benefit all.

    • Rami Manochakian
    • Don S. Dizon
    Comment
  • In this Comment article, Bhangu and Caduff describe how the social science of medical anthropology uses qualitative methods to better understand how people in different parts of the world perceive and experience illness, and how this field of study emphasizes research approaches that humanize and add richness to our understanding of cancer in complex settings.

    • Shagufta Bhangu
    • Carlo Caduff
    Comment
  • Complex therapies and multimodal interventions have become the gold standard approach for many of the most aggressive tumour types. However, there is a lack of models that enable the development and clinical translation of such treatment concepts. In this Comment, Saur and Schnieke present an argument for porcine cancer models filling this gap.

    • Dieter Saur
    • Angelika Schnieke
    Comment
  • mRNA vaccines have proven safe and effective in preventing serious illness and death during the COVID-19 pandemic. In this Comment, Morris and Kopetz argue that these technologies offer a novel approach towards personalizing immune-based treatments for patients with cancer with the potential for immune activation beyond commonly utilized immunotherapies.

    • Van K. Morris
    • Scott Kopetz
    Comment
  • The African Esophageal Cancer Consortium is a self-organized consortium of more than 80 physicians and scientists working in eastern and southern African countries. This Comment highlights the role that international collaborations with regional partners at their centre play in expanding local capacities for research and care to address cancer disparities.

    • Christian C. Abnet
    • Geoffrey C. Buckle
    • Russell E. White
    Comment
  • In this Comment, Deb et al. explore ‘cancer art’ projects that enable new conversations for a broader audience, advocate for policy and disparity issues, and lead to creative innovations for research.

    • Dhruba Deb
    • Stefani Shoreibah
    • Tal Danino
    Comment
  • In this Comment article, Alicea and Rebecca advocate for increased basic research and translational studies of acral lentiginous melanoma using the patient communities that suffer the most in order to develop therapies that benefit patients across all ethnic and racial groups.

    • Gretchen M. Alicea
    • Vito W. Rebecca
    Comment